Daniela Gioia

Statistics

Publications

Citations

778

H-Index

Active since

2001

Affiliations

Università degli Studi del Piemonte Orientale “Amedeo Avogadro”(Current)

Azienda Ospedaliero-Universitaria Careggi

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo

University of Turin

Daniela Gioia is an author at Università degli Studi del Piemonte Orientale “Amedeo Avogadro” specializing in medicine, oncology, and hematologic oncology.

Publications per year

2001–2021

Publications

Specific molecular signatures predict decitabine response in chronic myelomonocytic leukemia

Kristen Meldi, Tingting Qin, Francesca Buchi et al. · Journal of Clinical Investigation · 2015 · 178 citations · Full text

Medicine, Molecular Biology, Oncology +17

Interim Positron Emission Tomography Response–Adapted Therapy in Advanced-Stage Hodgkin Lymphoma: Final Results of the Phase II Part of the HD0801 Study

Pier Luigi Zinzani, Alessandro Broccoli, Daniela Gioia et al. · Journal of Clinical Oncology · 2016 · 148 citations · Full text

Medicine, Oncology, Chemotherapy +16

Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating Agents

Sophie Park, Jean-François Hamel, Andréa Toma et al. · Journal of Clinical Oncology · 2017 · 99 citations · Full text

Medicine, Hematology, Pharmacotherapy +14

Can the revised IPSS predict response to erythropoietic-stimulating agents in patients with classical IPSS low or intermediate-1 MDS?

Valeria Santini, Jennifer Schemenau, Alessandro Levis et al. · Blood · 2013 · 78 citations · Full text

Medicine, Hematology, Immunotherapy +6

A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia

Valeria Santini, B Allione, Gina Zini et al. · Leukemia · 2017 · 78 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

1–5 of 13